Topics:

All Content

Final results of the trial that led to FDA approval show that a new 9-valent HPV vaccine can reduce cases of HPV and cervical cancer.

Multiple myeloma patients had better overall survival if they had prior knowledge of having monoclonal gammopathy of undetermined significance.

The FDA has approved nivolumab (Opdivo) for the treatment of metastatic squamous non-small-cell lung cancer (NSCLC) in patients who have progressed on a platinum-based chemotherapy.

While chatting with a patient of mine this week, I suddenly realized I had forgotten how long it had been since she was diagnosed. Time moves strangely in the world of cancer, too slow to comfort us, too fast in spiriting us away.

Researchers have shown that reprogramming T cells to target glioblastoma in mice resulted in control of these tumors.

A new study yielded nomograms for the assessment of locally advanced cervical cancer, with prognostic factors including histology, performance status, and others.

The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.

A retrospective analysis suggested that a declining proportion of patients with lung cancer would meet the criteria for undergoing low-dose CT screening.

Researchers have identified patient factors linked with the discontinuation of ibrutinib therapy for reasons other than disease progression.

Advanced melanoma patients who received front-line ipilimumab/dacarbazine had double the 5-year survival rate compared with those on dacarbazine alone.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.